Guest speakers


Todd Margolis, MD, PhD
Director, F.I. Proctor Foundation; Professor and Rose B. Williams Chair in Corneal Research, UCSF

Dr. Margolis graduated from Stanford University and completed his medical training, graduate training and residency at UCSF. He subsequently completed clinical fellowship training in cornea and uveitis and a post-doctoral research fellowship in viral pathogenesis at UCLA. He has been on the faculty at UCSF since 1991 and is currently Director of the F.I. Proctor Foundation, and Professor and Rose B. Williams Chair in Corneal Research in the Department of Ophthalmology. His clinical practice focuses on infectious and inflammatory eye disease. Both his laboratory and clinical research focuses on herpesvirus infection of the eye.

Current Concepts II: Royal College Lecture: Ocular surface disease: Please don't call it dry eye


Ralph Chu
Chu Vision Institute, Bloomington MN USA

Dr. Chu received his medical degree from Northwestern University Medical School in Chicago, Illinois, where he was a member of the Alpha Omega Alpha Honor Society. He completed an internship at Evanston Hospital and an ophthalmology residency at Duke University Eye Center. Dr. Chu then completed a one-year fellowship in cornea and external disease, refractive surgery, cataract and lens implant surgery and glaucoma in Minneapolis.

As a certified VISX trainer, Dr. Chu has instructed thousands of physicians in many refractive surgery techniques including LASIK, PRK and PTK. He has participated in 24 clinical evaluations and 14 FDA studies dealing with cataract and intraocular lens implantations, phakic lens implantations, laser vision correction technologies and ocular therapeutic treatments.

Dr. Chu is a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgeons, the International Society of Refractive Surgery, along with 18 other professional memberships. He has been honored by selection to the editorial boards of Cataract and Refractive Surgery Today, Review of Ophthalmology, Refractive Surgery Quarterly, The Journal of Hennepin, Ramsey Medical Societies and Ophthalmology Management, New Ophthalmologist.

Dr. Chu has lectured and taught physicians on nearly every continent including Asia, Australia and Europe, and is a much sought after speaker, both nationally and internationally, regarding cataract and refractive surgery.

Current Concepts II: Astigmatism management of the cataract patient

Michael E. Snyder, MD
Surgical Faculty and Board of Directors, Cincinnati Eye Institute

Dr. Snyder began his medical studies in his home state at the University of Michigan. He pursued his initial ophthalmology residency training in Baltimore, Maryland, at Sinai Hospital, followed by subspecialty fellowship training in cornea, external disease, anterior segment and refractive surgery at New England Eye Center and Ophthalmic Consultants of Boston.

He was recruited to the Cincinnati Eye Institute in 1997, after a three-year tenure of clinical practice in Albany, New York. He has cultivated a subspecialty practice in Cincinnati, Ohio, and has special interests including complex cataract, trauma, iris repair and prostheses, and corneal transplant techniques.

Dr. Snyder is actively involved in clinical research, including FDA trials, on intraocualr lenses and artifical iris devices. He has authored and coauthored numerous journal articles, book chapters, and award-winning surgical videos. He enjoys lecturing locally, nationally, and internationally. He is a regular reviewer for Journal of Cataract and Refractive Surgery, Comprehensive Ophthalmology, and Cornea and sits on the Board of Directors of the Cincinnati Eye Institute and the Editorial Boards of EyeWorld and Cataract and Refractive Surgery Today.

Current Concepts I: An update on old and new iris prosthesis


Mark Morrow, MD
Clinical Professor, Chair and Residency Program Director, Department of Neurology at Harbor-UCLA Medical Center, Torrance, California

Dr. Mark Morrow grew up in Massachusetts and attended Boston University's Six-Year Medical Program. He trained in neurology at UCLA Medical Center before spending three years in neuro-ophthalmology fellowship with Dr. Jim Sharpe at the University of Toronto (1986-1989). He has spent his subsequent academic career at UCLA and Case Western Schools of Medicine, with a nine-year break for private practice. This included a four-year stint as associate director of the Providence Multiple Sclerosis Center in Portland, Oregon. He currently serves as Clinical Professor, Chairman and Residency Program Director of the Department of Neurology at Harbor-UCLA Medical Center in Torrance, California. His interests include ocular motor control and optic nerve disease, especially as it applies to multiple sclerosis.

Current Concepts I: Optic Neuritis and its Implications re: MS


Michael Crossland, PhD MCOptom FAAO

Dr Michael Crossland is a Research Fellow in Visual Neuroscience at the UCL Institute of Ophthalmology and a Specialist Optometrist at Moorfields Eye Hospital, London, UK. He received his PhD from the University of London in 2004, for work performed with Professor Gary Rubin on the visual performance of people with macular disease. His major research interest is in the psychophysics of visual impairment with particular reference to reading, fixation behaviour and detection of macular disease. His major clinical interest is low vision rehabilitation of people with visual field loss from macular disease or neurological scotomas. He is a Fellow of the American Academy of Optometry and a Member of the College of Optometrists, UK.

Current Concepts II: The importance of fixation stability in retinal disease

Fixation stability (the ability to hold the eye steady when observing a point target) is known to be associated with visual performance in people with retinal disease. In this presentation I will discuss the measurement of fixation stability, the relationship between fixation stability and performance on visual tasks, and the effects of rehabilitation and training on fixation stability.


Jacob Pe'er, MD
Chairman, Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Professor Jacob Pe'er, who was born in Tel Aviv, graduated from the Hebrew University-Hadassah Medical School in 1974. He specialized in Ophthalmology at the Hadassah-Hebrew University Medical Center, Jerusalem, and the Ophthalmic Pathology Department of the AFIP, Washington, DC.

In 1998 Professor Pe'er was appointed Professor and Chairman of the Department of Ophthalmology at Hadassah-Hebrew University Medical Center. He is currently the president of the International Society of Ocular Oncology. He is a member of the Board of Trustees of ARVO and of the ICO. His clinical and research interests center on the fields of ocular oncology and ophthalmic pathology.

Professor Pe'er has published over 220 papers, 40 chapters in books, and co-authored the book "Clinical Ophthalmic Oncology". He has presented over 450 lectures in national and international meetings.

Professor Pe'er is married and has three children.

Current Concepts III: Current approaches in diagnosis and treatment of vitreo-retinal lymphoma


William Trattler, MD
Director of Cornea, Center for Excellence in Eye Care

Dr. Trattler is the Director of Cornea at the Center for Excellence in Eye Care and is on the Volunteer faculty at Bascom Palmer Eye Institute and Florida International University School of Medicine's Department of Ophthalmology.

After graduating from Dartmouth College, he attended medical school at the University of Miami School of Medicine and completed his ophthalmology residency at the University of Pennsylvania, Scheie Eye Institute. He spent an additional year for subspecialty training in cornea and refractive surgery at the University of Texas Southwestern Medical Center in Dallas. Dr. Trattler has participated in numerous phase 3 and phase 4 studies in the areas of dry eye, blepharitis, refractive surgery, cataract surgery and new technologies such as corneal collagen crosslinking and intraoperative wavefront aberrometry during cataract surgery. Dr. Trattler was awarded Best Paper of Session for his research on accommodating intraocular lenses at the 2009 ASCRS meeting.

Dr. Trattler has authored many books, articles, and text book chapters including Microbiology Made Ridiculously Simple, a textbook he helped co-author that is used by medical, nursing, and veterinary students throughout the world. In 2002, Dr. Trattler received the Outstanding Young Ophthalmologist Leadership Award from the Florida Society of Ophthalmology. In 2006, he was named one of the top 50 Cataract & Refractive Surgery Opinion Leaders, as voted on by readers of Cataract & Refractive Surgery Today.

Dr. Trattler, is the Medical Editor for Eye Tube, an online resource for physicians with medical and surgical videos. Most recently, Dr. Trattler was named chief medical editor of Advanced Ocular Care, a new publication that reaches 17,000 eye care professionals in the United States.

Jes�s M. Merayo, MD, PhD, MBA, DO
Assistant Professor, University of Valladolid (UVA), Spain
Senior Scientist, Foundation for Research in Ophthalmology (FIO), Oviedo, Spain

Current Concepts II: Current Concepts on Ocular Allergy


Paul J. Foster, BMedSci(Hons) BM BS PhD FRCS(Ed) FRCOphth
UCL Reader and Honorary Consultant Ophthalmologist, National Biomedical Research Centre for Ophthalmology Division of Epidemiology and Genetics, UCL Institute of Ophthalmology and Glaucoma Service, Moorfields Eye Hospital, London

Paul Foster is Reader (Associate Professor) in Ophthalmic Epidemiology at the UCL Institute of Ophthalmology and a consultant ophthalmologist at Moorfields Eye Hospital in London. A graduate of Nottingham University Medical School, his SHO training was in the Oxford region, with registrar training on the North Thames/Moorfields rotation. In 2002 he was awarded a PhD for research on the epidemiology of glaucoma in East Asian people. He is a fellow of the Royal College of Surgeons of Edinburgh and of The Royal College of Ophthalmologists. Current scientific interests include the epidemiology and environmental determinants of glaucoma and refractive error, surgical management of glaucoma and screening and prevention of glaucoma in East Asia. Major research projects include

  • The EPIC-Norfolk Eye Study: a cohort of 10,000 people currently undergoing ocular phenotyping aimed at investigating novel environmental and genetic factors in eye disease
  • ZAP study: currently underway in Southern China, 10,000 people were screened to identify 700 with early stage angle-closure who have undergone laser iridotomy in one eye, with the fellow eye remaining untreated as a control. This study will assess the performance of prophylactic laser iridotomy in high risk individuals
  • Studies of the genetics of angle-closure glaucoma employing linkage and association techniques. We currently enrolled 86 families with multiple affected individuals
  • Collaborative studies with major scientific initiatives including The Wellcome Trust Case-Control Consortium 2 (WTCCC2), UKBiobank (UKBB), The Singapore Epidemiology of Eye Disease (SEEDS) and The Chinese American Eye Study (CHES) in Los Angeles.

Dr Foster has published 109 peer-reviewed papers, 14 book chapters and 3 journal editorials. Prior to appointment as a consultant, Dr Foster was elected a member of the Glaucoma Research Society which was then limited to 75 active members worldwide, promoting excellence in glaucoma research. He currently serves on the membership committee of the GRS. He is also a Council Member, International Society of Geographical and Epidemiological Ophthalmology and past chairman of the Associate Advisory Board of the World Glaucoma Association.

Current Concepts III: Assessment of the drainage angle, gonsicopy and imaging techniques

M. Cristina Leske, MD, MPH, DSc (hon)
SUNY Distinguished Professor Emeritus, SUNY Distinguished Service Professor Emeritus, Preventive Medicine and Ophthalmology, Stony Brook School of Medicine, Stony Brook NY

Dr. Leske served as department chair and led a national and international program in ophthalmic epidemiology and clinical trials. Her research contributions, documented in over 300 publications, have been recognized by her election to the Institute of Medicine, National Academy of Sciences, and by many awards, e.g., from the Harvard School of Public Health, the University of the West Indies, the Institute for Women's Health & Leadership, the AMWA/National Library of Medicine, and others.


Emmett T. Cunningham Jr, MD, PhD, MPH
Program Chair/Director, The Uveitis Service, California Pacific Medical Center
Adjunct Clinical Professor of Ophthalmology, Stanford University School of Medicine

Dr. Emmett T. Cunningham Jr. is currently director of the Uveitis Service at California Pacific Medical Center and adjunct clinical professor of ophthalmology at Stanford University School of Medicine.

Dr. Cunningham is an internationally recognized authority in the field of infectious and inflammatory eye disease, and has written over 200 publications. He was director of the Uveitis Service at the Francis I. Proctor Foundation and the Department of Ophthalmology at UCSF from 1996 to 2001 and from 2001 to 2005 served as director of the Uveitis Service and Clinical Professor of Ophthalmology at New York University School of Medicine.

Dr. Cunningham completed medical school at the Johns Hopkins University, residency training in ophthalmology at UCSF, a fellowship in corneal disease, external disease and uveitis at the Francis I. Proctor Foundation, a medical retina and uveitis fellowship at Moorfields Eye Hospital in London, and a fellowship in public health ophthalmology at the Wilmer Eye Institute.

Current Concepts: A practical approach to the use of corticosteroids in patients with uveitis


Gregg T. Lueder, MD
St. Louis Children's Hospital
Washington University School of Medicine
St. Louis, Missouri

Dr. Lueder is a Professor of Ophthalmology and Pediatrics at St. Louis Children's Hospital and the Washington University Medical School. He completed a pediatric residency at St. Louis Children's Hospital in 1988, an ophthalmology residency at the University of Iowa in 1991, and a fellowship in pediatric ophthalmology at the Hospital for Sick Children in Toronto in 1993. He has been board-certified by both the American Board of Pediatrics and the American Board of Ophthalmology.

Dr. Lueder currently is the Chair of the American Academy of Pediatrics Section on Ophthalmology. His research interests include lacrimal disorders and improving ophthalmic education for primary care physicians.

Current Concepts II: Saturday June 26 1345-1515
What shall I do with this child's eye?


Emily Y. Chew, MD
Deputy Director, Epidemiology and Clinical Research, National Eye Institute

Dr. Emily Y. Chew is the deputy director of the Division of Epidemiology and Clinical Research at the National Eye Institute. She earned her medical degree from University of Toronto. Following her residency in ophthalmology, also at the U. of Toronto, she completed fellowship training in medical retina at Johns Hopkins University and the University of Nijmegen in the Netherlands. She was an assistant professor at the University of Toronto for three years prior t o joining the National Eye Institute/National Institutes of Health in 1987.

Dr. Chew is an active member of the Clinical Trials Branch of the division. The ocular diseases evaluated with numerous clinical trials are diabetic retinopathy and age-related macular degeneration, two of the leading causes of blindness in America. The trials in diabetic retinopathy have resulted in highly effective strategies which may reduce the rates of severe vision loss by as much as 95 percent. Treatment with antioxidants and minerals has also lead to a reduction in vision loss in patients with age-related macular degeneration. This is the first trial to show such an improvement in this ocular condition.

Dr. Chew chairs committees associated with the American Academy of Ophthalmology regarding educational materials for residents and practicing ophthalmologists, worldwide.

She is on the editorial boards of medical journals in the fields of ophthalmology and diabetes.

The coauthor of more than 100 publications and book chapters, Dr. Chew has been a featured lecturer at numerous national and international professional symposia. She continues her research focus on improving the treatment of patients with diabetic retinopathy and age-related macular degeneration.

Current Concepts III: Monday June 28 0830-1000
Update on age-related macular degeneration

Robert P. Murphy, MD
Retina Group of Washington, Fairfax, VA

Dr. Robert Murphy graduated from Northwestern University Medical School and completed residencies in Internal Medicine at the University of California, Irvine, and Ophthalmology at the Stanford University Medical School. After completing fellowships in both medical and surgical retina at the Wilmer Eye Institute, he remained on the ophthalmology faculty at Johns Hopkins for twelve years before entering private practice with the Retina Group of Washington. He is a participant in several macular degeneration clinical trials. He is a member of the AAO, ARVO, the Retina Society, the Macula Society, the Club Jules Gonin, and the American Society of Retinal Specialists.

Current Concepts II: Saturday June 26 1345-1515
Advances in Diagnostic Testing -- FA, ICG and OCT


Michael Kazim, MD
Clinical Professor of Ophthalmology and Surgery
Columbia University Medical Center
New York, NY


Paul Courtright PhD
Co-director, Kilimanjaro Centre for Community Ophthalmology, Tumaini University, Moshi, Tanzania

Dr. Paul Courtright is co-director of the Kilimanjaro Centre for Community Ophthalmology (KCCO) of Tumaini University in Moshi, Tanzania. He and his wife, Dr. Susan Lewallen, established the KCCO - the largest ophthalmic research and community ophthalmology training centre in Africa - in 2001.

Prior to this time he established and directed the British Columbia Centre for Epidemiologic and International Ophthalmology (1995-2001) at the University of British Columbia. He is on faculty at the University of British Columbia with joint appointments in the Department of Ophthalmology and Department of Health Care and Epidemiology.

He has also lived and worked in Malawi (4 years), Ethiopia (1 year), Egypt (1 year), and Korea (4 years). His DrPH is from the University of California, Berkeley (1988) and he has an MPH from Johns Hopkins University (1984). He also underwent the fellowship in preventive ophthalmology at the JHU Wilmer Eye Institute (1983-4). Most of his published work (over 150 scientific articles) has been carried out in Africa and Asia.

He and his wife are recipients of the 2008 "International Blindness Prevention Award" of the American Academy of Ophthalmology. He serves on committees for the World Health Organization, International Agency for the Prevention of Blindness, and other organizations and served as Executive Secretary of the International Society for Geographical & Epidemiological Ophthalmology from 1994-2008.

His particular areas of interest are in trachoma, gender and blindness, health systems research, cataract, paediatric cataract, eye complications of leprosy, and other conditions common in developing countries.